Lilly to test COVID-19 antibody drug in unorthodox nursing home study — Prepare for an influx of cell and gene therapy approvals — Regeneron pairs with BioNTech on melanoma immunotherapy — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page

Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.